Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a campaign intended to help people change their perception of what they can achieve.

SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the ...

and on World Diabetes Day (Nov. 14), Dexcom is teaming up with its thousands of global brand advocates – Dexcom Warriors and Stelo Ambassadors, including Nick Jonas, Lance Bass, Retta ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what they ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what ...

Shares of DexCom Inc. DXCM advanced 2.96% to $74.68 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.60% to 5,949.17 and ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ ... index generated a median return of 4% between election day in November and calendar year-end, as per Goldman Sachs.

In March, the FDA cleared Dexcom’s Stelo, making it the first ... showing when users’ glucose levels spike and ebb throughout the day. “When someone sees their own personal data, that ...

the company reported that it has submitted a 15-day version of its G7 sensor to the FDA for review. Currently, the device can be worn for up to 10 days among users as young as 2 years old. Dexcom ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity maintained a Buy rating on the ...

DexCom (DXCM) reported $994.2 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 2%. EPS of $0.45 for the same period compares to $0.50 a year ago.